Zoetis: Your Partner for One Health Research Alliances

Zoetis: Your Partner for One Health Research Alliances

Considering that 60 percent of human infectious diseases originate with animals, there is an undeniable connection between human and animal health.

Zoetis, the leading global animal health company, understands this connection and the need for partnerships to help improve the health and well-being of animals and the people who care for them.  Zoetis partners with Kansas City Area Life Sciences Institute (KCALSI) as a sponsor of both the 2015 and 2016 KCALSI Animal Health Research Symposiums on “The Growing Risk of Zoonotic and Vector-Borne Diseases.”

Zoetis advocates for a One Health approach linking human health, animal health and ecosystems. Our company believes tools and technology that protect companion animal health and support production of healthy livestock can positively impact public health and safe, affordable food. Solutions for newly emerging infectious diseases in animals can help protect human health. Collaboration between human and veterinary researchers can potentially advance understanding of mutually relevant diseases like osteoarthritis, kidney disease, cardiovascular disease and certain cancers.

Zoetis is the partner of choice for organizations with similar One Health goals. Our company’s significant expertise in livestock and companion animal health translates into powerful partnerships with those working in animal health, pharmaceuticals, biotechnology, agribusiness and academia. These collaborative partnerships with Zoetis combine complementary talents, expertise and passion with the expertise to advance science and deliver innovative products.

Potential collaborations include:

  • Applying in vivo models to help accelerate pre-clinical research
  • Sharing compound libraries
  • Shortening the cycle from research to collaboration by validating molecular targets in animal disease
  • Opening alternative revenue sources for animal health uses of products
  • Using Zoetis expertise in veterinary biopharmaceuticals (monoclonal antibodies and protein therapeutics) to evaluate targets in non-rodent species

More information on partnering with Zoetis through a One Health approach »

Share: